rs17112751
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001278.5(CHUK):c.475-137A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0497 in 641,502 control chromosomes in the GnomAD database, including 1,561 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.076 ( 787 hom., cov: 32)
Exomes 𝑓: 0.041 ( 774 hom. )
Consequence
CHUK
NM_001278.5 intron
NM_001278.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.44
Publications
2 publications found
Genes affected
CHUK (HGNC:1974): (component of inhibitor of nuclear factor kappa B kinase complex) This gene encodes a member of the serine/threonine protein kinase family. The encoded protein, a component of a cytokine-activated protein complex that is an inhibitor of the essential transcription factor NF-kappa-B complex, phosphorylates sites that trigger the degradation of the inhibitor via the ubiquination pathway, thereby activating the transcription factor. [provided by RefSeq, Jul 2008]
CHUK Gene-Disease associations (from GenCC):
- cocoon syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- Bartsocas-Papas syndrome 2Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 10-100219496-T-C is Benign according to our data. Variant chr10-100219496-T-C is described in ClinVar as Benign. ClinVar VariationId is 1288291.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.173 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0759 AC: 11543AN: 152054Hom.: 771 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
11543
AN:
152054
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0415 AC: 20285AN: 489330Hom.: 774 AF XY: 0.0417 AC XY: 10939AN XY: 262474 show subpopulations
GnomAD4 exome
AF:
AC:
20285
AN:
489330
Hom.:
AF XY:
AC XY:
10939
AN XY:
262474
show subpopulations
African (AFR)
AF:
AC:
2396
AN:
13270
American (AMR)
AF:
AC:
1542
AN:
23584
Ashkenazi Jewish (ASJ)
AF:
AC:
335
AN:
15828
East Asian (EAS)
AF:
AC:
3033
AN:
31508
South Asian (SAS)
AF:
AC:
3615
AN:
51322
European-Finnish (FIN)
AF:
AC:
2206
AN:
32742
Middle Eastern (MID)
AF:
AC:
135
AN:
2126
European-Non Finnish (NFE)
AF:
AC:
5742
AN:
291420
Other (OTH)
AF:
AC:
1281
AN:
27530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
939
1878
2817
3756
4695
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0762 AC: 11599AN: 152172Hom.: 787 Cov.: 32 AF XY: 0.0804 AC XY: 5980AN XY: 74418 show subpopulations
GnomAD4 genome
AF:
AC:
11599
AN:
152172
Hom.:
Cov.:
32
AF XY:
AC XY:
5980
AN XY:
74418
show subpopulations
African (AFR)
AF:
AC:
7304
AN:
41496
American (AMR)
AF:
AC:
944
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
72
AN:
3472
East Asian (EAS)
AF:
AC:
497
AN:
5182
South Asian (SAS)
AF:
AC:
356
AN:
4816
European-Finnish (FIN)
AF:
AC:
787
AN:
10602
Middle Eastern (MID)
AF:
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1406
AN:
67998
Other (OTH)
AF:
AC:
148
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
514
1027
1541
2054
2568
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
335
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 11, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.